论文部分内容阅读
急性心肌梗死是心血管疾病的急危重症,其发病率及病死率呈逐年上升且年轻化趋势发展,已成为世界各国主要致死原因之一。近年来随着AMI发病机制的深入研究,为AMI的早期诊断、危险度分层、预后判断提供了新方向。其中,人们逐渐认识到作为炎症标志物的hs-CRP对急性心肌梗死的发生、发展及预后具有预测意义,NT-proBNP作为一种明确的可定量分析心功能状态的标志物已应用于临床。
Acute myocardial infarction (AMI) is an emergent and critical disease of cardiovascular disease. Its morbidity and mortality are increasing year by year and developing younger. It has become one of the major causes of death in all countries in the world. In recent years, with the in-depth study of the pathogenesis of AMI, AMI provides a new direction for the early diagnosis of AMI, risk stratification, prognosis. Among them, people gradually come to realize that hs-CRP, as a marker of inflammation, has predictive significance for the occurrence, development and prognosis of acute myocardial infarction. NT-proBNP has been used clinically as a definite marker for quantitative analysis of cardiac function.